CSIMarket Company Name, Ticker, Customers, else..
 
Cerus Corporation  (NASDAQ: CERS)
 

Cerus's Suppliers Performance

CERS's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
CERS Costs vs Sales of Suppliers Growth

• More on CERS Suppliers






Cerus's Comment on Supply Chain


The company utilizes third-party suppliers for manufacturing in the U.S. market and assists blood center manufacturing partners in obtaining Biologics License Applications (BLAs) for INTERCEPT-treated products. It faces risks associated with supply or manufacturing issues or delays from its suppliers, many of whom are sole qualified providers of specific products or components. These suppliers are required to maintain FDA approval and comply with current Good Manufacturing Practices (cGMP) and Quality System Regulation (QSR) standards. Both the company and its suppliers must produce sufficient quantities to meet increasing demand. Additionally, risks exist related to third-party suppliers used by the company's customers in combination with its products. The company also contracts with blood center manufacturers for the production of IFC and the purchase of kits.

Cerus's Comment on Supply Chain


The company utilizes third-party suppliers for manufacturing in the U.S. market and assists blood center manufacturing partners in obtaining Biologics License Applications (BLAs) for INTERCEPT-treated products. It faces risks associated with supply or manufacturing issues or delays from its suppliers, many of whom are sole qualified providers of specific products or components. These suppliers are required to maintain FDA approval and comply with current Good Manufacturing Practices (cGMP) and Quality System Regulation (QSR) standards. Both the company and its suppliers must produce sufficient quantities to meet increasing demand. Additionally, risks exist related to third-party suppliers used by the company's customers in combination with its products. The company also contracts with blood center manufacturers for the production of IFC and the purchase of kits.







CERS's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Cerus Corporation 525.48 221.22 -6.83 288
SUBTOTAL 0.00 0.00 0.00 -


Sources: Cerus Corporation's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Cerus Corporation’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.